MedPath

Comparison of the effect of ketorolac and intravenous lidocaine on fentanyl-induced cough in surgery

Phase 3
Completed
Conditions
Fentanyl induced Cough.
Cough
Registration Number
IRCT20220102053599N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
210
Inclusion Criteria

aged 18 to 60 years, with and with, who
any gender
ASA 1 or 2
referred to Firoozgar and Hazrat Rasul-e Akram hospitals and are candidates for elective surgery that lasts more than an hour
in the period of April 2022 to June 2022

Exclusion Criteria

Preoperative pulmonary emphysema
Bronchial asthma
History of upper respiratory infection during the last 2 weeks
Smoking
Hypertension
Coronary artery disease
Has a chronic cough that makes it difficult to diagnose fentanyl-induced cough
High pressure inside the eyes, brain or abdomen
Taking anti-anxiety and anti-depressant drugs before surgery
Taking anti-cough medicines (codeine, dextromethorphan, baclofen, steroids or bronchodilators) during the last week
BMI above 28 kg/m2
History of chronic opioid use
Taking cough medicines (ACEI & ABR)
History of GERD or peptic ulcer
History of kidney or liver disease
Pregnancy or breastfeeding
Known allergy to fentanyl or ketorolac
G6PD deficiency disease
High risk of GIB
Patient reluctance

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cough. Timepoint: Within 90 seconds of fentanyl injection. Method of measurement: observation.
Secondary Outcome Measures
NameTimeMethod
Cough Intensity. Timepoint: Within 90 seconds of fentanyl injection. Method of measurement: Observation.;Cough start time. Timepoint: Within 90 seconds of fentanyl injection. Method of measurement: Stopwatch.
© Copyright 2025. All Rights Reserved by MedPath